In this video, Dr. Bharat Kumar talks about the seven virtues of rheumatology practice that clinicians should embrace and what deadly sins to avoid.

In this video, Dr. Bharat Kumar talks about the seven virtues of rheumatology practice that clinicians should embrace and what deadly sins to avoid.
Donald Thomas, MD, FACP, FACR, RhMSUS, & Jason Liebowitz, MD |
“ANA’s are some of most commonly ordered tests but what exactly are they and what do you do with a positive ANA? Check out the Editor’s Pick for October to learn more,” says Physician Editor Bharat Kumar, MD, MME, FACP, FAAAAI, RhMSUS.
1949 was a momentous year—astronomer Fred Hoyle coined the term Big Bang, the North Atlantic Treaty Organization (NATO) was formed, and Rodgers and Hammerstein’s classic musical South Pacific opened on Broadway.1 Much less recognized was the publication of an essay by Richard Asher, FRCP, titled the “Seven Sins of Medicine.”2 Although it’s over 75 years…
Improving reimbursement for underwater biosimilars is just one example of how the ACR’s practice advocates have achieved solutions to members’ insurance challenges. Here’s a look at current ACR efforts in insurance advocacy and how to get help with your own insurance challenges.
Katie Robinson |
Systemic lupus erythematosus (SLE) is a prototypic autoimmune disease that primarily affects young women and causes a wide range of inflammatory manifestations. Its hallmark is the production of antibodies to components of the cell nucleus (anti-nuclear antibodies [ANAs]). …
Alexandros Grivas, MD, Nikil Revuri, MD, Aleksandra Karaseva, MD, Basimah AlBalooshy, MD, & Andres M. Ponce, MD |
Here, we present a case of inflammatory cerebral amyloid angiopathy, discussing its diverse clinical manifestations, diagnostic challenges in view of recently proposed clinical-radiologic criteria and its management.
Bryn Nelson, PhD |
An unusual autoimmune inner ear condition results in hearing loss, but is reversible if treated.
Kanika Monga, MD, FACR |
“While our group carefully considered your application, I regret to inform you that you were not selected this year to serve as a committee volunteer.” When the email arrived, gently delivering the news that my application to volunteer with the ACR on a committee had not been accepted, my initial reaction was to dismiss it…
Amanda Moyer, MD, & Tamiko Katsumoto, MD |
In this case report, a patient with voriconazole-induced periostitis exhibits classic symptoms & elevated ALP levels, which quickly resolve following the discontinuation of voriconazole.
Philip Seo, MD, MHS |
Summaries of selected research abstracts on ANCA-associated vasculitis & IgA vasculitis from the International Vasculitis Workshop.
Bonita Libman, MD |
Sheldon Mark Cooper, MD, MACR, professor of medicine, and a colleague and mentor throughout my career at the University of Vermont, Burlington, passed away June 6, after a long illness. Dr. Cooper was born in The Bronx, New York, in 1942, earning his medical degree from New York University School of Medicine in 1967. He…
Medicare’s extended telehealth services will expire at the end of the year unless Congress acts to continue them. Make sure your legislators know how a failure to act will harm patient access to care.
Yvonne Golightly, PT, MS, PhD, & Aileen Ledingham, PT, MA, PhD |
Some patients avoid using canes due to stigma, but cane use can prevent loss of mobility and increase independence for many.
Ioannis Koulas, MD, MS |
The 2024 Rheumatology Research Workshop facilitated educational and relationship-building experiences for early-career and established rheumatology professionals alike.
Emily A. Johnson, JD |
The FTC issued a Final Rule that banned non-compete agreements, but the rule was recently halted by a nationwide injunction from a federal court in Texas.
Marko Radic, PhD, & Georg Schett, MD, were awarded the 2024 Lupus Insight Prize for advances in CAR-T cell therapy.
The FDA accepted a new drug application for suzetrigine, a non-opioid analgesic, based on the results from clinical trials in patients with neuropathy and those post-surgery.
In a study, all doses of LEVI-04 demonstrated significant pain relief for patients with knee osteoarthritis compared with placebo.
Background & Objectives The ORAL Surveillance trial (NCT02092467), a postauthorization safety study of tofacitinib in patients with rheumatoid arthritis (RA) aged 50 years or older with at least one additional cardiovascular risk factor, found a dose-dependent increase in venous thromboembolism (VTE) and pulmonary embolism (PE) events when patients were treated with tofacitinib vs. a tumor…